Once monthly injectables to become future therapeutic options for obesity: Report
New Delhi, Jan 12 (IANS) From once-weekly subcutaneously injectable medicines agonizing the glucagon-like peptide 1 receptor (GLP-1R), longer-acting candidates allowing once-monthly administration may become the next generation of obesity management drugs, according to a report.